NeuroPace (NASDAQ:NPCE) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.22) by 18.18 percent. This is a 21.74 percent increase over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $21.47 million which beat the analyst consensus estimate of $21.17 million by 1.39 percent. This is a 19.18 percent increase over sales of $18.01 million the same period last year.